journal article·2018Open access

Distribution of superparamagnetic Au/Fe nanoparticles in an isolated guinea pig brain with an intact blood brain barrier

Barbara Sanavio, Laura Librizzi, Paolo Pennacchio, Galina V. Beznoussenko, Fernanda Sousa, Paulo Jacob Silva, Alexander A. Mironov, Carolina Frassoni, Francesco Stellacci, Marco de Curtis, Silke Krol

Nanoscale· Volume 10· Issue 47

Abstract

Diagnosis and treatment of brain disorders, such as epilepsy, neurodegenerative diseases and tumors, would benefit from innovative approaches to deliver therapeutic or diagnostic compounds into the brain parenchyma, with either a homogeneous or a targeted localized distribution pattern. To assess the mechanistic aspect of penetration of nanoparticles (NPs) into the brain parenchyma, a complex, yet controlled and facilitated environment was used: the isolated guinea pig brain maintained in vitro by arterial perfusion. In this unique preparation the blood-brain barrier and the interactions between vascular and neuronal compartments are morphologically and functionally preserved. In this study, superparamagnetic Au/Fe nanoparticles (MUS:OT Au/Fe NPs), recently studied as a promising magnetic resonance T2 contrast agent with high cellular penetration, were arterially perfused into the in vitro isolated brain and showed high and homogeneous penetration through transcytosis into the brain parenchyma. Ultramicroscopy investigation of the in vitro isolated brain sections by TEM analysis of the electron-dense core of the MUS:OT Au/Fe NPs was conducted to understand NPs' brain penetration through the BBB after in vitro arterial perfusion and their distribution in the parenchyma. Our data suggest that MUS:OT Au/Fe NPs enter the brain utilizing a physiological route and therefore can be exploited as brain penetrating nanomaterials with potential contrast agent and theranostics capabilities.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanomedicine Laboratory

Fondazione IRCCS Istituto Neurologico Carlo Besta

20133 Milan

Italy

Neurophysiology Laboratory

Clinical and Experimental Epileptology Unit

Laboratory of Developmental Neuroanatomy

IFOM

The FIRC Institute of Molecular Oncology

20139 Milan

Institute of Materials

Ecole Polytechnique Fédérale de Lausanne (EPFL)

STI IMX SUNMIL

MXG 030 (Bâtiment MXG)

CH-1015 Lausanne

IRCCS Istituto Tumori “Giovanni Paolo II”

Funding

Ministero della Salute · Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · Associazione Italiana per la Ricerca sul Cancro · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

References (41)

Show source-provided references
1. Allen · Science · 2004 · 303 · 181810.1126/science.1095833 ↗
2. Dinda · Curr. Pharm. Biotechnol. · 2013 · 14 · 126410.2174/1389201015666140608143719 ↗
3. Pelaz · ACS Nano · 2017 · 11 · 231310.1021/acsnano.6b06040 ↗
4. Ellis-Behnke · Curr. Pharm. Des. · 2007 · 13 · 251910.2174/138161207781368648 ↗
5. Blanco · Nat. Biotechnol. · 2015 · 33 · 94110.1038/nbt.3330 ↗
6. Lockman · J. Drug Targeting · 2004 · 12 · 63510.1080/10611860400015936 ↗
7. Voigt · Eur. J. Pharm. Biopharm. · 2014 · 87 · 1910.1016/j.ejpb.2014.02.013 ↗
8. Balogh · Nanomedicine · 2010 · 6 · 50110.1016/j.nano.2010.06.001 ↗
9. Aparicio-Blanco · Biomaterials · 2016 · 103 · 22910.1016/j.biomaterials.2016.06.051 ↗
10. Smith · J. Drug Targeting · 2006 · 14 · 19110.1080/10611860600650086 ↗
11. Banks · BMC Neurol. · 2009 · 9 · S310.1186/1471-2377-9-S1-S3 ↗
12. Canton · Chem. Soc. Rev. · 2012 · 41 · 271810.1039/c2cs15309b ↗
13. Duncan · Mol. Pharm. · 2012 · 9 · 238010.1021/mp300293n ↗
14. de Curtis · Brain Res. Protoc. · 1998 · 3 · 22110.1016/S1385-299X(98)00044-0 ↗
15. Librizzi · J. Neurosci. Res. · 2001 · 66 · 28910.1002/jnr.1223 ↗
16. Mazzetti · Brain Res. · 2004 · 999 · 8110.1016/j.brainres.2003.11.032 ↗
17. de Curtis · J. Neurosci. Methods · 2016 · 260 · 8310.1016/j.jneumeth.2015.03.026 ↗
18. Sousa · Bioconjugate Chem. · 2017 · 28 · 16110.1021/acs.bioconjchem.6b00577 ↗
19. Verma · Nat. Mater. · 2008 · 7 · 58810.1038/nmat2202 ↗
20. Van Lehn · Nano Lett. · 2013 · 13 · 406010.1021/nl401365n ↗
21. Carney · ACS Nano · 2013 · 7 · 93210.1021/nn3036304 ↗
22. Atukorale · Bioconjugate Chem. · 2018 · 29 · 113110.1021/acs.bioconjchem.7b00777 ↗
23. Sousa · Nanoscale · 2010 · 2 · 282610.1039/c0nr00345j ↗
24. Krol · J. Controlled Release · 2012 · 164 · 14510.1016/j.jconrel.2012.04.044 ↗
25. Andreozzi · Mol. Pharm. · 2013 · 10 · 87510.1021/mp300530c ↗
26. Mühlethaler · Eur. J. Neurosci. · 1993 · 5 · 91510.1111/j.1460-9568.1993.tb00942.x ↗
27. Schindelin · Nat. Methods · 2012 · 9 · 67610.1038/nmeth.2019 ↗
28. Mironov · Eur. J. Cell Biol. · 2004 · 83 · 26310.1078/0171-9335-00377 ↗
29. Beznoussenko · Methods Mol. Biol. · 2015 · 1270 · 32110.1007/978-1-4939-2309-0_23 ↗
30. Beznoussenko · Histochem. Cell Biol. · 2016 · 146 · 51510.1007/s00418-016-1483-y ↗
31. Kolpakov · Atherosclerosis · 1996 · 122 · 17310.1016/0021-9150(95)05735-8 ↗
32. Preibisch · Bioinformatics · 2009 · 25 · 146310.1093/bioinformatics/btp184 ↗
33. Cox · ACS Nano · 2018 · 12 · 729210.1021/acsnano.8b03500 ↗
34. Carney · Nat. Commun. · 2011 · 2 · 33510.1038/ncomms1338 ↗
35. Leduc · ACS Nano · 2011 · 5 · 258710.1021/nn1023285 ↗
36. Liu · Appl. Spectrosc. Rev. · 2014 · 49 · 12110.1080/05704928.2013.807817 ↗
37. Lipinski · Adv. Drug Delivery Rev. · 2016 · 101 · 3410.1016/j.addr.2016.04.029 ↗
38. Pardridge · J. Cereb. Blood Flow Metab. · 2012 · 32 · 195910.1038/jcbfm.2012.126 ↗
39. Chevalier · Morphologie · 2017 · 101 · 5510.1016/j.morpho.2017.04.001 ↗
40. Verma · Small · 2010 · 6 · 1210.1002/smll.200901158 ↗
41. Uzun · Chem. Commun. · 2008 · 19610.1039/B713143G ↗